Cite

HARVARD Citation

    de Nonneville, A. et al. (2018). Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer. Journal of geriatric oncology. 9 (3), pp. 281-283. [Online]. 
  
Back to record